Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment

被引：8

作者：

Andersen, NH ^{[1
]}

Mogensen, CE ^{[1
]}

机构：

[1] Univ Hosp, Kommunehosp, Dept Internal Med, DK-8000 Aarhus C, Denmark

来源：

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM | 2001年 / 2卷 / 03期

关键词：

ACE inhibition; angiotensin II receptor blockade; hypertension; nephropathy; congestive heart failure; dual blockade;

D O I：

10.3317/jraas.2001.020

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

[No abstract available]

引用

页码：146 / 152

页数：7

共 55 条

[11]

COHN JN, 2000, CIRCULATION, V102, P2672

[12] Characteristics of 9194 patients with left ventricular hypertrophy -: The LIFE study [J].

Dahlöf, B ;

Devereux, RB ;

Julius, S ;

Kjeldsen, SE ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Hedner, T ;

Ibsen, H ;

Kristianson, K ;

Lederballe-Pedersen, O ;

Lindholm, LH ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H .

HYPERTENSION, 1998, 32 (06) :989-997

[13] A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension [J].

Fagard, R ;

Lijnen, P ;

Pardaens, K ;

Thijs, L ;

Vinck, W .

JOURNAL OF HUMAN HYPERTENSION, 2001, 15 (03) :161-167

[14] Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure [J].

Hamroff, G ;

Katz, SD ;

Mancini, D ;

Blaufarb, I ;

Bijou, R ;

Patel, R ;

Jondeau, G ;

Olivari, MT ;

Thomas, S ;

Le Jemtel, TH .

CIRCULATION, 1999, 99 (08) :990-992

[15] Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].

Hansson, L ;

Zanchetti, A ;

Carruthers, SG ;

Dahlöf, B ;

Elmfeldt, D ;

Julius, S ;

Ménard, J ;

Rahn, KH ;

Wedel, H ;

Westerling, S .

LANCET, 1998, 351 (9118) :1755-1762

[16] Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy [J].

Hebert, LA ;

Falkenhain, ME ;

Nahman, NS ;

Cosio, FG ;

O'Dorisio, TM .

AMERICAN JOURNAL OF NEPHROLOGY, 1999, 19 (01) :1-6

[17] Pathways for angiotensin II generation in intact human tissue - Evidence from comparative pharmacological interruption of the renin system [J].

Hollenberg, NK ;

Fisher, NDL ;

Price, DA .

HYPERTENSION, 1998, 32 (03) :387-392

[18] Salt intake and non-ACE pathways for intrarenal angiotensin II generation in man [J].

Hollenberg, NK ;

Osei, SY ;

Lansang, MC ;

Price, DA ;

Fisher, NDL .

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2001, 2 (01) :14-18

[19] Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta [J].

Ihara, M ;

Urata, H ;

Kinoshita, A ;

Suzumiya, J ;

Sasaguri, M ;

Kikuchi, M ;

Ideishi, M ;

Arakawa, K .

HYPERTENSION, 1999, 33 (06) :1399-1405

[20] Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease - A meta-analysis of patient-level data [J].

Jafar, TH ;

Schmid, CH ;

Landa, M ;

Giatras, I ;

Toto, R ;

Remuzzi, G ;

Maschio, G ;

Brenner, BM ;

Kamper, A ;

Zucchelli, P ;

Becker, G ;

Himmelmann, A ;

Bannister, K ;

Landais, P ;

Shahinfar, S ;

de Jong, PE ;

de Zeeuw, D ;

Lau, J ;

Levey, AS .

ANNALS OF INTERNAL MEDICINE, 2001, 135 (02) :73-87

← 1 2 3 4 5 6 →